Welcome to our dedicated page for Healthcare Tr Amer SEC filings (Ticker: HR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthcare Realty Trust Incorporated (NYSE: HR) files a range of reports and disclosure documents with the U.S. Securities and Exchange Commission (SEC) that provide detailed information about its operations as a healthcare‑focused real estate investment trust. This page aggregates those SEC filings for HR and pairs them with AI‑generated summaries to help readers understand the key points in each document.
In its periodic filings, such as the Annual Report on Form 10‑K and Quarterly Reports on Form 10‑Q, Healthcare Realty presents consolidated financial statements, portfolio data and management’s discussion and analysis. These filings expand on metrics referenced in the company’s earnings releases, including rental income from medical outpatient buildings, property operating expenses, funds from operations (FFO), normalized FFO, funds available for distribution (FAD), leverage measures and information about its medical outpatient building portfolio and development pipeline.
Current reports on Form 8‑K provide timely updates on specific events. For Healthcare Realty, recent 8‑Ks have addressed topics such as quarterly earnings and dividend announcements, changes to the Board of Directors, the appointment and departure of its Executive Vice President and Chief Financial Officer, amendments to its revolving credit and term loan facilities and the establishment of an at‑the‑market equity offering program. These filings often include or reference press releases, supplemental information packages and credit agreements.
Investors can also use this page to access other SEC documents related to Healthcare Realty, such as registration statements and exhibits describing its unsecured credit facilities and equity distribution agreements. For those monitoring governance and executive matters, 8‑K filings under Item 5.02 outline executive appointments, employment agreement terms, severance and change‑in‑control provisions.
Stock Titan enhances these filings with AI‑powered tools. Real‑time updates from the SEC’s EDGAR system ensure that new 10‑K, 10‑Q and 8‑K filings appear promptly. AI‑generated summaries highlight key financial metrics, capital structure changes, portfolio updates and governance actions, helping readers navigate lengthy documents more efficiently. Users can also review insider‑related information when reported on Forms 3, 4 or 5, and examine proxy‑related disclosures when filed, to better understand executive compensation and board structure.
Whether you are analyzing Healthcare Realty’s leverage and liquidity, reviewing its credit facilities and equity offering programs, or tracking leadership and board changes, this SEC filings page provides a centralized view of the company’s regulatory disclosures with added AI context.
Healthcare Realty Trust furnished a business update presentation outlining 2025 results, balance sheet progress, and its Healthcare Realty 2.0 strategic plan. The outpatient medical REIT owns 33 million square feet across 562 properties and reported 2025 normalized FFO of $1.61 per share, with same-store cash NOI up 4.8% and occupancy at 92.1%.
Net debt to adjusted EBITDA improved to 5.4x after about $1.2 billion of asset sales, $650 million of term loan repayments, and $250 million of senior note repayments, contributing to $1.4 billion of liquidity and BBB/Baa2 credit ratings. The company right-sized its dividend to $0.24 per quarter (5.2% yield on a $0.96 annualized rate) and repurchased $50 million of stock in January 2026, with $450 million of authorization remaining.
For 2026, guidance calls for normalized FFO of $1.58–$1.64 per share and same-store cash NOI growth of 3.5%–4.5%. Management highlights high occupancy, a largely fixed-rate debt stack with a 3.2% weighted average rate, a 36% total debt-to-assets ratio, and targeted 9%–12% returns on a ~$300 million redevelopment pipeline as key drivers of future earnings growth.
Healthcare Realty Trust Inc executive vice president and chief financial officer Daniel Gabbay reported stock awards in the company’s common stock. On January 12, 2026, he acquired 159,051 shares as a grant or award. On February 9, 2026, he received an additional 32,107 shares as a similar grant.
After these transactions, Gabbay directly owned 191,158 shares of common stock. The filing notes that it was submitted after the usual deadline due to unanticipated delays in obtaining filer codes for the reporting person.
Healthcare Realty Trust Inc executive vice president and chief financial officer Daniel Gabbay filed an initial ownership report on Form 3 for the company’s common stock. The filing shows he held no shares of common stock directly as of the reported date. A footnote explains the filing was made after the normal deadline because of unexpected delays in obtaining filer codes for the reporting person.
Healthcare Realty Trust Incorporated reported that its Audit Committee has appointed Deloitte & Touche LLP as the company’s independent registered public accounting firm, effective February 19, 2026, replacing BDO USA, P.C.
BDO’s audit reports on the company’s financial statements for the years ended December 31, 2024 and 2025 contained no adverse opinions, disclaimers, or qualifications. The company states there were no disagreements or reportable events with BDO under the SEC’s Regulation S-K definitions during those years and through February 19, 2026. BDO provided a letter agreeing with the company’s description of these matters, filed as Exhibit 16.
Healthcare Realty Trust Inc. executive vice president and chief investment officer Ryan E. Crowley reported a tax-withholding disposition of common stock. On 02/13/2026, 736 shares were withheld at $17.96 per share to cover taxes on vesting restricted stock, leaving him with 198,504 directly owned shares.
Healthcare Realty Trust Incorporated files its annual report describing a large medical office–focused REIT platform and key 2025 developments. The company held about $10.3 billion of consolidated real estate investments across 502 properties, plus $453.6 million in unconsolidated joint ventures, with overall occupancy around 90% as of December 31, 2025.
In 2025, Healthcare Realty Trust sold 70 properties for roughly $1.1 billion, generating about $1.0 billion of net cash proceeds at a 6.7% disposition capitalization rate, and invested $136.6 million in development and redevelopment projects. The portfolio is diversified by tenant, with no single tenant contributing 10% or more of consolidated revenue.
The REIT reports $4.1 billion of debt and recorded $361.1 million of impairment charges in 2025 tied to dispositions, holding-period changes and property use changes. Management highlights risks from tenant financial health, healthcare regulation, interest rates, significant 2026–2027 debt maturities, cybersecurity, environmental obligations and maintaining REIT tax status. The company emphasizes ESG initiatives, detailed governance structures and a workforce of 539 employees supporting its outpatient healthcare strategy.
Healthcare Realty Trust reported solid operating momentum for Q4 2025 while continuing to reshape its portfolio and balance sheet. For the quarter, GAAP net income was $14.4 million, or $0.04 per share, with NAREIT FFO of $0.36 and Normalized FFO of $0.40 per share. Same-store cash NOI grew 5.5%, helped by 82.7% tenant retention and 3.7% cash leasing spreads, and the company executed 1.5 million square feet of leases.
For full-year 2025, the company posted a GAAP net loss of $0.71 per share but generated NAREIT FFO of $1.38 and Normalized FFO of $1.61 per share, supported by 4.8% same-store cash NOI growth. Management completed $1.2 billion of asset sales at a 6.7% blended cap rate, reduced Net Debt to Adjusted EBITDA to 5.4x from 6.1x, repaid roughly $650 million of term loans and $250 million of senior notes, and extended its $1.5 billion revolver to July 2030. The Board declared a $0.24 per share dividend and the company repurchased 2.9 million shares for $50 million. New 2026 guidance calls for earnings per share between $(0.05) and $0.05, NAREIT FFO per share of $1.44–$1.50, Normalized FFO per share of $1.58–$1.64, and same-store cash NOI growth of 3.5–4.5%. Healthcare Realty also established an inaugural commercial paper program of up to $600 million to expand its short-term funding options.
Healthcare Realty Trust Inc. executive Ryan E. Crowley, EVP and CIO, reported equity compensation and related tax withholding transactions in company common stock. On February 9, 2026, he acquired 32,788 shares as a grant at
To cover required tax withholding tied to vesting of previously granted restricted shares, the issuer withheld 968 shares on February 9, 2026 at
Healthcare Realty Trust Inc. executive Andrew Edward Loope, EVP and General Counsel, reported equity compensation and related tax withholding transactions in company common stock. On February 9, 2026, he acquired 32,588 shares of common stock at $17.13 per share in a grant or award, bringing his direct holdings to 191,060 shares.
Also on February 9 and on February 10, 2026, a total of 5,574 shares (2,924 and 3,650 shares) were disposed of at prices of $17.13 and $17.36 per share, respectively, to satisfy required tax withholding obligations in connection with vesting of previously granted restricted shares. After these transactions, he directly owned 184,486 shares of common stock.
Healthcare Realty Trust Inc. senior vice president and chief accounting officer Amanda L. Callaway reported equity compensation and related tax withholding transactions in company common stock. On 02/09/2026, she acquired 34,689 shares as a grant at
Also on 02/09/2026, 2,769 shares were disposed of at